Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,036 | 7,607 | 5,629 | N/A | N/A |
| Marketable Securities | 32,950 | 43,396 | 41,090 | N/A | N/A |
| Receivables | 2,146 | 7,803 | 2,652 | N/A | N/A |
| Other current assets | 347 | 417 | 1,693 | 0 | 0 |
| TOTAL | $56,479 | $59,224 | $51,063 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,493 | 2,292 | 2,216 | N/A | N/A |
| Investments And Advances | 14,692 | 5,989 | 13,735 | 0 | 0 |
| TOTAL | $17,185 | $8,281 | $15,950 | $N/A | $N/A |
| Total Assets | $73,664 | $67,505 | $67,013 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,762 | 1,473 | 1,790 | 0 | 0 |
| Other current liabilities | 488 | 468 | 457 | N/A | N/A |
| TOTAL | $2,259 | $1,949 | $2,255 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $2 | $5 | $N/A | $N/A |
| Total Liabilities | $2,259 | $1,951 | $2,259 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,390 | 12,364 | N/A | N/A | N/A |
| Common Shares | 16 | 16 | 16 | N/A | N/A |
| Retained earnings | -17,909 | -23,159 | -23,621 | N/A | N/A |
| Other shareholders' equity | 166 | -63 | -61 | 0 | 0 |
| TOTAL | $71,405 | $65,554 | $64,754 | $N/A | $N/A |
| Total Liabilities And Equity | $73,664 | $67,505 | $67,013 | $0 | $0 |